Glostrup University Hospital, Copenhagen
Clinical trials sponsored by Glostrup University Hospital, Copenhagen, explained in plain language.
-
Could a gut bacteria supplement stop MS in its tracks?
Disease control Recruiting nowThis study is testing whether a supplement called indole-3-propionic acid (IPA), a natural substance made by gut bacteria, can help control multiple sclerosis. Researchers will give the supplement to 220 adults with relapsing-remitting MS to see if it reduces flare-ups, prevents …
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New program aims to empower arthritis patients from day one
Disease control Recruiting nowThis study is testing a new self-management program designed to help people recently diagnosed with inflammatory arthritis. 130 participants in Denmark will be randomly assigned to receive either the new program plus usual care, or just usual care alone. The program involves sess…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC
-
New program aims to ease the strain on family members caring for loved ones with arthritis
Symptom relief Recruiting nowThis study is testing a new support program for family members and friends who provide unpaid care for older adults with rheumatoid arthritis (RA) and frailty. The program involves a few meetings with a trained professional over 12 weeks to help caregivers manage stress, find res…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC